¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð Á¶»ç : Ä¡·á À¯Çüº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Growth Hormone Deficiency Market Size study, by Treatment Type, by Disease Indication, by Route of Administration, by Distribution Channel and Regional Forecasts 2022-2032
»óǰÄÚµå : 1529456
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀåÀº 2023³â ¾à 43¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 4.49% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ºÀåÈ£¸£¸ó °áÇÌÁõ(GHD)Àº ¼ºÀåÈ£¸£¸óÀÌ Ã¼³»¿¡¼­ ÃæºÐÈ÷ ºÐºñµÇÁö ¾Ê´Â ÁúȯÀ¸·Î, ¼Ò¾ÆÀÇ °æ¿ì ¼ºÀå°ú ¹ßÀ°À», ¼ºÀÎÀÇ °æ¿ì Á¶Á÷°ú Àå±âÀÇ °Ç°­ À¯Áö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¹°ÁúÀÔ´Ï´Ù. ¼Ò¾ÆÀÇ °æ¿ì GHD°¡ ÀÖÀ¸¸é °°Àº ³ªÀÌÀÇ ¾ÆÀ̵鿡 ºñÇØ ۰¡ ÇöÀúÈ÷ ÀÛ°í »çÃá±â°¡ ´Ê¾îÁö¸ç ¾ó±¼°ú º¹ºÎ ÁÖº¯ÀÇ Áö¹æÀÌ Áõ°¡ÇÕ´Ï´Ù. ¼ºÀÎÀÇ °æ¿ì °ñ¹Ðµµ °¨¼Ò, ±ÙÀ°·® °¨¼Ò, ÇǷΰ¨, ½ÉÇ÷°ü Áúȯ À§Çè Áõ°¡ µîÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¼ö ÀÖ½À´Ï´Ù. Áø´ÜÀº Á¾Á¾ È£¸£¸ó ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â Ç÷¾× °Ë»ç, ÀÚ±Ø °Ë»ç, ³ú ¿µ»ó °Ë»ç µîÀ» ÅëÇØ ÀÌ·ç¾îÁý´Ï´Ù. Ä¡·á´Â ÀϹÝÀûÀ¸·Î ¼ºÀå°ú ´ë»ç ±â´ÉÀÇ Á¤»óÈ­¸¦ µ½±â À§ÇØ ÇÕ¼º ¼ºÀå È£¸£¸óÀ» ÁÖ±âÀûÀ¸·Î ÁÖ»çÇÏ´Â ¼ºÀå È£¸£¸ó ´ëü ¿ä¹ýÀ» Æ÷ÇÔÇÕ´Ï´Ù. Á¶±â Áø´Ü°ú ÀϰüµÈ Ä¡·á´Â GHD ȯÀÚÀÇ ¿¹ÈÄ¿Í »îÀÇ ÁúÀ» °³¼±ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¼¼°è ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀåÀº ¼¼°è ¼ºÀåÈ£¸£¸ó °áÇÌÁõ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä Ã˸ÅÁ¦ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È£¸£¸ó ºÒ±ÕÇü¿¡ Ãë¾àÇÑ ³ë³âÃþ Àα¸ Áõ°¡´Â ¼ºÀåÈ£¸£¸ó Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È£¸£¸ó ºÐºñ Àå¾Ö¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå È®´ë°¡ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ºÀåÈ£¸£¸ó Ä¡·á´Â ¼ºÀåÈ£¸£¸ó °áÇÌÁõ°ú °ü·ÃµÈ ´Ù¾çÇÑ Áõ»óÀ» Á¶±â¿¡ Áø´ÜÇϰí È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±×·¯³ª ¼ºÀåÈ£¸£¸ó Ä¡·áÀÇ °ü¸® ¹× ¸ð´ÏÅ͸µ¿¡ ÇÊ¿äÇÑ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä¡·á ¿ä¹ýÀÇ º¹À⼺°ú ÀáÀçÀûÀÎ ºÎÀÛ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀ̸ç, 2023³â ºÏ¹Ì°¡ ¼ºÀå È£¸£¸ó ¿ä¹ýÀ» Áö¹èÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼´Â ¿¹Ãø ±â°£ µ¿¾È Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ªÀû ¿ìÀ§´Â ¹Ì±¹ÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾî ÅõÀÚ Áõ°¡¿Í ¼ºÀåÈ£¸£¸ó °áÇÌÁõ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦3Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Ä¡·á À¯Çüº°, 2022-2032³â

Á¦6Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÀûÀÀ Áúȯº°, 2022-2032³â

Á¦7Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Åõ¿© °æ·Îº°, 2022-2032³â

Á¦8Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Åë ä³Îº°, 2022-2032³â

Á¦9Àå ¼¼°èÀÇ ¼ºÀåÈ£¸£¸ó °áÇÌÁõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

Á¦10Àå °æÀï Á¤º¸

Á¦11Àå Á¶»ç °úÁ¤

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Growth Hormone Deficiency Market is valued approximately at USD 4.38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.49% over the forecast period 2024-2032. Growth Hormone Deficiency (GHD) is a medical condition where the body does not produce enough growth hormone, a critical substance responsible for growth and development in children and maintaining tissue and organ health in adults. In children, GHD can result in significantly shorter stature compared to peers, delayed puberty, and increased fat around the face and stomach. In adults, symptoms might include reduced bone density, decreased muscle mass, fatigue, and a higher risk of cardiovascular diseases. Diagnosis often involves blood tests to measure hormone levels, stimulation tests, and imaging studies of the brain. Treatment typically includes growth hormone replacement therapy, which involves regular injections of synthetic growth hormone, helping to normalize growth and metabolic functions. Early diagnosis and consistent treatment are crucial for improving outcomes and quality of life for individuals with GHD.

The Global Growth Hormone Deficiency Market is driven by rising incidence of growth hormone deficiencies worldwide is a primary catalyst for market growth. Additionally, the increasing geriatric population, who are more prone to hormonal imbalances, further propels the demand for growth hormone treatments. Furthermore, growing awareness about hormonal deficiencies is anticipated to bolster market expansion. Growth hormone treatments play a critical role in enabling early diagnosis and effective management of various conditions associated with growth hormone deficiency. However, the market faces challenges, such as the shortage of skilled professionals required to administer and monitor growth hormone therapies. Additionally, the complexity of treatment regimens and potential side effects may hinder market growth.

The key regions considered for the Global Growth Hormone Deficiency Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the growth hormone therapy landscape, a trend expected to continue throughout the forecast period. This regional dominance is attributed to favorable reimbursement policies in the U.S. and a well-established healthcare infrastructure. Furthermore, Asia-Pacific region is anticipated to witness substantial growth, driven by increasing healthcare investments and rising awareness about growth hormone deficiencies.

Major market players included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

By Disease Indication:

By Route of Administration:

By Distribution Channel:

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Growth Hormone Deficiency Market Executive Summary

Chapter 2. Global Growth Hormone Deficiency Market Definition and Research Assumptions

Chapter 3. Global Growth Hormone Deficiency Market Dynamics

Chapter 4. Global Growth Hormone Deficiency Market Industry Analysis

Chapter 5. Global Growth Hormone Deficiency Market Size & Forecasts by Treatment Type 2022-2032

Chapter 6. Global Growth Hormone Deficiency Market Size & Forecasts by Disease Indication 2022-2032

Chapter 7. Global Growth Hormone Deficiency Market Size & Forecasts by Route of Administration 2022-2032

Chapter 8. Global Growth Hormone Deficiency Market Size & Forecasts by Distribution Channel 2022-2032

Chapter 9. Global Growth Hormone Deficiency Market Size & Forecasts by Region 2022-2032

Chapter 10. Competitive Intelligence

Chapter 11. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â